Delivery Order SPE2DB22D1017-SPE2DB24FG6AY

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $29K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Orencia Clickject 125 mg/ml medication. The contract, valued at $42,402.29, was awarded by the Defense Logistics Agency (DLA) and has a completion date of June 21, 2024. The contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,663.84, is for the delivery of Orencia Clickject 125 mg/ml medication. It is a firm fixed-price delivery order with an ultimate completion date of October 31, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor and holds an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orencia ClickJect 125 mg/mL. The contract has a ceiling value of $3,331.92 and is a firm fixed-price delivery order, with a completion date of September 18, 2024. This contract is not associated with any set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award, valued at $3,640.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Orencia Clickject 125 mg/ml, a pharmaceutical product. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 28, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orencia ClickJect 125 mg/ml medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $24,594.92. The contract has an ultimate completion date of August 8, 2024. This award does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orencia ClickJect 125 mg/mL medication. The $3,387.36 firm fixed price delivery order has a completion date of September 24, 2024. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, has extensive experience supplying a wide range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $29,943.35, is for the delivery of Orencia Clickject 125 mg/ml medication. It is a firm fixed-price delivery order contract with an ultimate completion date of August 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orencia ClickJect 125 mg/ml medication. The award has a total ceiling value of $3,594.04 and is structured as a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,266.25 delivery order contract is for the supply of Orencia ClickJect 125 mg/mL, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of October 26, 2023. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,572.03 firm fixed-price delivery order is for the supply of Orencia ClickJect 125 mg/mL, a specialty medication. The contract has an ultimate completion date of January 31, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG6AY
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orencia Clickject 125 mg/mL medication. The contract, valued at $29,254.35, is a delivery order with a firm fixed-price pricing type. The ultimate completion date is September 30, 2024. This contract award is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office division, will deliver the specified pharmaceutical product to support the healthcare needs of the U.S. military and federal government agencies. The company is an experienced federal contractor, holding several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation for a wide range of medical commodities and prescription drugs.

Generated 12/27/24, 9:12 AM